Friday, July 23, 2021

Medication Guide - 7/23/2021

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Bydureon Exenatide Synthetic FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS 022200 ASTRAZENECA AB 07/22/2021
Bydureon Bcise Exenatide SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS 209210 ASTRAZENECA AB 07/22/2021
Morphine Sulfate Morphine Sulfate SOLUTION;ORAL 022195 HIKMA 07/22/2021
Keytruda Pembrolizumab POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER 125514 MERCK SHARP DOHME 07/21/2021
Oxycodone Hydrochloride Oxycodone Hydrochloride CAPSULE;ORAL 200534 GENUS LIFESCIENCES 07/21/2021
Oxycodone Hydrochloride Oxycodone Hydrochloride SOLUTION;ORAL 200535 GENUS LIFESCIENCES 07/21/2021
Oxycodone Hydrochloride Oxycodone Hydrochloride SOLUTION;ORAL 201194 VISTAPHARM 07/21/2021
Methylin Methylphenidate Hydrochloride SOLUTION;ORAL 021419 SPECGX LLC 07/19/2021

 


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment